Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$3.28M |
| 2 |
United Parcel Service
UPS
|
+$2.89M |
| 3 |
Campbell Soup
CPB
|
+$2.55M |
| 4 |
West Pharmaceutical
WST
|
+$2.5M |
| 5 |
UnitedHealth
UNH
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$6.83M |
| 2 |
Warner Bros
WBD
|
+$3.61M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.6M |
| 4 |
Advanced Micro Devices
AMD
|
+$3.43M |
| 5 |
Microchip Technology
MCHP
|
+$2.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.98% |
| 2 | Consumer Staples | 22.39% |
| 3 | Technology | 14.63% |
| 4 | Communication Services | 9.36% |
| 5 | Materials | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ASML
ASML
$677B
| $6.55M | 3.81% |
6,768
-948
| -12% | -$745K |
|
|
2
Warner Bros
WBD
$71.6B
| $6.46M | 3.76% |
330,727
-264,820
| -44% | -$3.61M |
|
3
Estee Lauder
EL
$36.9B
| $6.23M | 3.62% |
70,688
-10,911
| -13% | -$972K |
|
4
CVS Health
CVS
$119B
| $6.21M | 3.61% |
82,359
-10,638
| -11% | -$729K |
|
5
Boeing
BA
$169B
| $6.15M | 3.58% |
28,492
-3,085
| -10% | -$696K |
|
6
GSK
GSK
$105B
| $6.12M | 3.56% |
141,779
-10,820
| -7% | -$423K |
|
7
Microsoft
MSFT
$3.59T
| $5.94M | 3.46% |
11,470
-1,625
| -12% | -$829K |
|
8
DuPont de Nemours
DD
$18.7B
| $5.54M | 3.23% |
56,702
-8,802
| -13% | -$829K |
|
9
Pfizer
PFE
$160B
| $5.52M | 3.21% |
216,552
-18,076
| -8% | -$446K |
|
10
Kraft Heinz
KHC
$30.3B
| $5.5M | 3.2% |
211,151
+1,420
| +0.7% | +$38.6K |
|
|
11
Campbell Soup
CPB
$7.14B
| $5.46M | 3.18% |
173,034
+78,824
| +84% | +$2.55M |
|
12
AB InBev
BUD
$155B
| $5.41M | 3.15% |
90,738
+3,645
| +4% | +$229K |
|
13
Baxter International
BAX
$13.6B
| $5.39M | 3.14% |
236,603
+58,174
| +33% | +$1.48M |
|
14
Biogen
BIIB
$32B
| $5.37M | 3.13% |
38,354
-3,618
| -9% | -$489K |
|
15
Zimmer Biomet
ZBH
$19.3B
| $5.2M | 3.03% |
52,815
-2,783
| -5% | -$276K |
|
16
Nike
NKE
$60.5B
| $5.17M | 3.01% |
74,155
-16,688
| -18% | -$1.24M |
|
17
Brown-Forman Class B
BF.B
$13.1B
| $5.1M | 2.97% |
188,254
+12,466
| +7% | +$361K |
|
18
International Flavors & Fragrances
IFF
$21.5B
| $4.88M | 2.84% |
79,264
+4,584
| +6% | +$315K |
|
19
CarMax
KMX
$8.82B
| $4.11M | 2.39% |
91,489
+11,879
| +15% | +$709K |
|
20
Verizon
VZ
$205B
| $3.2M | 1.86% |
72,697
-6,830
| -9% | -$296K |
|
21
Becton Dickinson
BDX
$52.3B
| $3.15M | 1.83% |
16,814
-9
| -0.1% | -$1.67K |
|
22
Walt Disney
DIS
$186B
| $3.14M | 1.83% |
27,452
-1,310
| -5% | -$154K |
|
23
Bristol-Myers Squibb
BMY
$137B
| $3.13M | 1.82% |
69,440
-2,375
| -3% | -$111K |
|
24
TSMC
TSM
$2.17T
| $3.12M | 1.82% |
11,175
-4,924
| -31% | -$1.2M |
|
25
T. Rowe Price
TROW
$23.8B
| $3.05M | 1.77% |
29,708
-8,586
| -22% | -$902K |
|
Similar funds
Mark Hillman's Q3 2025 Portfolio in Review
As of Q3 2025, Mark Hillman held 55 positions worth $172M, down 6.2% from $183M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mark Hillman withdrew a net $15.3M in Q3 2025, closing 2 positions and reducing 31 holdings. Its most notable exit was AT&T, an estimated $6.83M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Mark Hillman opened a new position in Fiserv Inc worth $2.95M.
- Mark Hillman's largest Q3 2025 buy was Fiserv Inc: 22,900 shares worth $2.95M.
- Mark Hillman added most to Campbell Soup in Q3 2025, an estimated $2.55M increase.
- Mark Hillman's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $3.61M.
- Mark Hillman fully exited AT&T in Q3 2025, selling an estimated $6.83M.
- Mark Hillman's ten largest holdings make up 35% of its $172M portfolio in Q3 2025.
- Mark Hillman opened 5 new positions and closed 2 in Q3 2025.
- Mark Hillman's portfolio value fell 6.2% quarter-over-quarter to $172M.
Based on Hillman Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.